| 2010 March |
Hexima produces first transgenic corn plants as part of collaboration with DuPont business Pioneer Hi-Bred International |
| 2010 February |
Hexima enters research cross licences with Monsanto |
| 2010 February |
New corn transformation facility is completed and receives PC2 certification |
| 2009 November |
Hexima and Australian Centre for Plant Functional Genomics announce strategic alliance for improvement of cereal crops |
| 2009 November |
Hexima extends human disease program |
| 2009 August |
Third consecutive year of positive results in cotton fields of its anti-fungal disease technology |
| 2009 July |
Professor Marilyn Anderson appointed Chief Science Officer |
| 2009 July |
Hexima awarded $1.38 million Climate Ready Grant |
| 2009 July |
Hexima announces MGEV Research Licence with DuPont business Pioneer
Hi-Bred International |
| 2008 December |
Lease for site at La Trobe University for construction of glasshouse complex |
| 2008 November |
Service Agreement with CSIRO to breed Hexima defensin genes into elite cotton germplasm |
| 2008 October |
Third field trial of fungal resistant cotton expressing the defensin gene planted |
| 2008 August |
Development and Commercialisation Agreement for fungal disease resistance technology signed with DuPont business Pioneer Hi-Bred International Inc |
| 2008 July |
Mr Joshua Hofheimer appointed Chief Executive Officer |
| 2008 July |
Positive results from second field trial of cotton expressing the defensin gene |
| 2008 February |
Dr Mark Hulett appointed Vice President Research |
| 2008 January |
Transgenic canola expressing defensin genes produced in glasshouse |
| 2007 October |
Second field trial of fungal resistant cotton expressing the defensin gene planted |
| 2007 August |
$40M raised in an Initial Public Offering. Hexima Limited listed on the ASX. |
| 2007 August |
Ms Justine Heath appointed Chief Financial Officer and Company Secretary |
| 2007 August |
Positive results from third field trial of cotton expressing PI genes |
| 2007 August |
Positive results from first field trial of cotton expressing the defensin gene |
| 2007 August |
Collaboration with Dow AgroSciences on cotton seed development |
| 2006 October |
Third AusIndustry Grant awarded (Commercial Ready Grant) |
| 2006 October |
Third field trial of cotton expressing PI genes planted |
| 2006 October |
First field trial of fungal resistant cotton expressing the defensin gene planted |
| 2006 September |
Execution of Collaborative Agreement with global agribusiness group |
| 2006 July |
Bio-assays demonstrate an additive effect when PI technology is combined with Bt technology |
| 2006 July |
Expression of proteins other than proteinase inhibitors in the Multigene Expression Vehicle (MGEV) in transgenic cotton |
| 2006 July |
Execution of Collaborative Agreement with global agribusiness group |
| 2005 November |
Acquisition of 50% interest in Cyclotide Patent portfolio from La Trobe University |
| 2005 July |
Proof of concept of anti-fungal properties of defensin in cotton in glasshouse trials |
| 2005-06 |
Second field trial of cotton expressing PI genes – positive results in a high insect pressure year |
| 2004-05 |
Institutional Biosafety Committee (IBC) established and Office of the Gene Technology Regulator (OGTR) application lodged |
| 2004-05 |
First field trial of cotton expressing PI genes – positive results |
| 2004 |
Execution of two agreements with global agribusiness groups |
| 2004 |
Second AusIndustry Grant awarded (R&D Start Grant) |
| 2003 |
Proof of concept of two gene product in glasshouse (enhanced insect resistance demonstrated) |
| 2002-03 |
Second generation plants developed expressing two PI genes |
| 2000-02 |
Proof of concept of NaPI in glasshouse (limited insect resistance demonstrated) |
| 2001 |
First AusIndustry Grant awarded (R&D Start Grant) |
| 2000-01 |
First GM cotton plants expressing NaPI produced |
